FDA slaps a full hold on Affimed's T cell engager in wake of a lethal reaction
The hold that Affimed execs put on one of their top development programs at the beginning of last week is no longer voluntary. The FDA …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
